The largest database of trusted experimental protocols

Rapamycin pellets

Manufactured by Innovative Research
Sourced in United States

Rapamycin pellets are a laboratory product used for research purposes. They contain the compound rapamycin, which is a macrolide antibiotic with immunosuppressant and anti-proliferative properties. The pellets provide a controlled and consistent delivery of rapamycin for experimental studies.

Automatically generated - may contain errors

4 protocols using rapamycin pellets

1

Rapamycin Effects on Obese Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal procedures used in this study were approved by the Harry S. Truman Veterans Memorial Hospital (HSTVMH) Subcommittee for Animal Safety and University of Missouri IACUC before commencing. All animals were cared for in accordance with the Guidelines for the Care and Use of Laboratory Animals (National Institutes of Health publication 85-23). Zucker obese (fa/fa) (ZO) and lean (ZL) rats (Charles River Laboratories) were used in this study. Rats were maintained on ad libitum food and water and housed singly at the HSTVMH animal housing facility under standard laboratory conditions. Room temperature was maintained at 21-22°C. Light and dark cycles were for 12 hours, but animals were entrained to have dark cycle (awake time) during the day and light cycle (sleep time) during the night. At 8 weeks of age, Rapamycin pellets designed to deliver Rap at a concentration of 750 μg/kg/day for 21 days (from Innovative Research of America Inc., Sarasota, FL) or placebo (sugar) pellets were placed surgically under the skin behind the shoulder blades under brief isoflurane anesthesia and this procedure was repeated 3 times to achieve a 12-week treatment. ZL and ZO rats that received placebo pellets are referred to as ZL-C and ZO-C and those implanted with Rapamycin pellets are referred to as ZL-Rap and ZO-Rap, respectively, in the text.
+ Open protocol
+ Expand
2

Rapamycin Treatment in Zucker Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal procedures used in this study were approved by the Harry S. Truman Veterans Memorial Hospital (HSTVMH) Subcommittee for Animal Safety and University of Missouri IACUC before commencing. All animals were cared for in accordance with the Guidelines for the Care and Use of Laboratory Animals (National Institutes of Health publication 85-23). Zucker obese (fa/fa) (ZO) and lean (ZL) rats (Charles River Laboratories) were used in this study. Rats were maintained on ad libitum food and water and housed singly at the HSTVMH animal housing facility under standard laboratory conditions (room temperature: 21– 22°C; light and dark cycles: 12h). Food intake was monitored by placing a pre-weighed amount of food in the cage and determining the weight of leftover food after 24 hrs. At 8-weeks of age, rapamycin pellets designed to deliver Rap at a concentration of 750µg/kg/day for 21 days (from Innovative Research of America, Inc, Sarasota, FL) or placebo pellets were placed surgically under the skin behind the shoulder blades under brief isoflurane anesthesia and this procedure was repeated 3 times to achieve a 12-week treatment. Body composition was determined using the EchoMRI 4in1/1100 as described previously (18 (link)). Hearts were harvested at time of sacrifice as described before (18 (link)), flash frozen in liquid nitrogen, and stored at -80°C for future use.
+ Open protocol
+ Expand
3

Rapamycin Pellet Implantation in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rapamycin pellets were made by Innovative Research (Sarasota, Florida, USA) with a dose of 9.45 mg per pellet with a 21-day release time. This results in a 2.5 mg/kg dose per day across the 21-day period. This pellet dose and window of administration was chosen based on a prior study [97 (link)]. The pellets were implanted in the midscapular region using a 7-gauge trocar under isoflurane anesthesia. Rats were given oral meloxicam (1.0 mg/kg) for pain before and 24 hours following the surgery. Pellet implantation was done at 3 weeks of age and the 21-day rapamycin release ending at 6 weeks of age. As a control, rats were implanted with a vehicle pellet. Y-maze testing was done when rats were 6 weeks old, novel object when rats were 6.6 weeks old, and social behavior when rats were 7.1 to 7.4 weeks old.
+ Open protocol
+ Expand
4

Rapamycin Treatment in Zucker Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal procedures used in this study were approved by the Harry S. Truman Veterans Memorial Hospital (HSTVMH) Subcommittee for Animal Safety and University of Missouri IACUC before commencing. All animals were cared for in accordance with the Guidelines for the Care and Use of Laboratory Animals (National Institutes of Health publication 85-23). Zucker obese (fa/fa) (ZO) and lean (ZL) rats (Charles River Laboratories) were used in this study. Rats were maintained on ad libitum food and water and housed singly at the HSTVMH animal housing facility under standard laboratory conditions (room temperature: 21– 22°C; light and dark cycles: 12h). Food intake was monitored by placing a pre-weighed amount of food in the cage and determining the weight of leftover food after 24 hrs. At 8-weeks of age, rapamycin pellets designed to deliver Rap at a concentration of 750µg/kg/day for 21 days (from Innovative Research of America, Inc, Sarasota, FL) or placebo pellets were placed surgically under the skin behind the shoulder blades under brief isoflurane anesthesia and this procedure was repeated 3 times to achieve a 12-week treatment. Body composition was determined using the EchoMRI 4in1/1100 as described previously (18 (link)). Hearts were harvested at time of sacrifice as described before (18 (link)), flash frozen in liquid nitrogen, and stored at -80°C for future use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!